# Oxford Immunotec Global PLC

Oxford Immunotec Global PLC is a company headquartered in Abingdon, United Kingdom.

## Company overview

- **Legal name:** Oxford Immunotec Global PLC
- **Classification:** Company
- **Industry (SIC):** 2835 — In Vitro & In Vivo Diagnostic Substances
- **Headquarters:** Abingdon, United Kingdom
- **Incorporated in:** X0
- **Fiscal year end:** December 31
- **SEC CIK:** 0001586049

## About

Oxford Immunotec Global PLC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001586049, and its reported industry is In Vitro & In Vivo Diagnostic Substances. In 10-K filed on 2020-03-06, it reported annual revenue of USD 73,710,000; net income of USD -1,809,000; total assets of USD 235,252,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $73.7M (USD 73,710,000)
- **Net income:** -$1.8M (USD -1,809,000)
- **Total assets:** $235.3M (USD 235,252,000)
- **Cash and equivalents:** $181.3M (USD 181,270,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $59.8M (USD 59,753,000)
- **Net income:** $120.8M (USD 120,779,000)
- **Total assets:** $232.1M (USD 232,120,000)
- **Cash and equivalents:** $192.8M (USD 192,844,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $103.1M (USD 103,080,000)
- **Net income:** -$32.9M (USD -32,885,000)
- **Total assets:** $144.2M (USD 144,236,000)
- **Cash and equivalents:** $90.3M (USD 90,332,000)
- **Operating cash flow:** -$3.6M (USD -3,586,000)

### FY2016 (period ended 2016-12-31)

- **Revenue:** $86.1M (USD 86,078,000)
- **Net income:** -$22.3M (USD -22,349,000)
- **Total assets:** $124.0M (USD 124,012,000)
- **Cash and equivalents:** $59.1M (USD 59,110,000)
- **Operating cash flow:** -$21.9M (USD -21,921,000)

## Recent SEC filings

- Form SC 13G — filed 2021-05-07 — SCHEDULE 13G
- Form SC 13G — filed 2021-03-08
- Form 8-K — filed 2021-03-08 — period 2021-03-08 — 8-K
- Form 8-K — filed 2021-02-26 — period 2021-02-26 — 8-K
- Form SC 13G — filed 2021-02-16 — SCHEDULE 13G HOLDINGS REPORT
- Form SC 13G — filed 2021-02-12 — ENDURANT13GOXFD
- Form SC 13G — filed 2021-02-11 — OXFORD IMMUNOTEC GLOBAL SC 13G
- Form SC 13G — filed 2021-02-03
- Form SC 13D — filed 2021-01-29 — SC 13D
- Form 8-K — filed 2021-01-07 — period 2021-01-07 — FORM 8-K
- Form 8-K — filed 2020-11-30 — period 2020-11-30 — FORM 8-K
- Form 10-Q — filed 2020-11-03 — period 2020-09-30 — FORM 10-Q

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/oxford-immunotec-global-plc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology